Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States

Newborn screening for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is mandated throughout the US. Filter paper blood specimens are assayed for 17-hydroxyprogesterone (17OHP). Prematurity, low birth weight, or critical illness cause falsely elevated results. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Speiser, Phyllis W., Chawla, Reeti, Chen, Ming, Diaz-Thomas, Alicia, Finlayson, Courtney, Rutter, Meilan M., Sandberg, David E., Shimy, Kim, Talib, Rashida, Cerise, Jane, Vilain, Eric, Délot, Emmanuèle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422998/
https://www.ncbi.nlm.nih.gov/pubmed/32832708
http://dx.doi.org/10.3390/ijns6020037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422998/
https://www.ncbi.nlm.nih.gov/pubmed/32832708
http://dx.doi.org/10.3390/ijns6020037

Ejemplares similares